Dai Chihara, MD
UT MD Anderson Cancer Center · M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dai Chihara, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07917832 · Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell LymphomaM.D. Anderson Cancer Center · not yet recruiting · Multi Center, Phase 2, Golcadomide · principal investigator
- N/ANCT07829445 · PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCLM.D. Anderson Cancer Center · recruiting · LBCL, Comprehensive Genomic, Precision Treatment · principal investigator
- Ph2NCT07783594 · Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphomaM.D. Anderson Cancer Center · not yet recruiting · Randomized, Phase 2, Epcoritamab · principal investigator
- Ph2NCT07316010 · Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell LymphomaM.D. Anderson Cancer Center · recruiting · Large B-cell Lymphoma · principal investigator
- Ph2NCT06670105 · A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell LymphomaM.D. Anderson Cancer Center · withdrawn · B-cell Lymphoma · principal investigator
- Ph2NCT06563505 · A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone LymphomaM.D. Anderson Cancer Center · recruiting · Lymphoma · principal investigator
- Ph2NCT06045247 · Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell LymphomaM.D. Anderson Cancer Center · recruiting · Large B-cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.